LFCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lifecore Biomedical Inc (LFCR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock is oversold based on RSI and shows potential for short-term gains, the lack of positive financial performance, weak trading sentiment, and absence of significant catalysts make it less appealing for long-term investment. Holding or waiting for further developments is recommended.
The stock is currently oversold with an RSI of 11.128, indicating potential for a rebound. However, the MACD histogram is negative (-0.163) and expanding downward, signaling bearish momentum. The stock is trading near its support level (S1: 7.044), with resistance levels at R1: 8.538 and R2: 8.999. Moving averages are converging, suggesting indecision in the market.
The stock is oversold, which may attract short-term buyers. Gross margin has improved by 14.81% YoY, signaling operational efficiency.
Net income dropped significantly (-32.76% YoY), and EPS declined sharply (-45.28% YoY). No recent news or significant insider/hedge fund activity. Weak trading sentiment as indicated by high put-call ratios.
In Q1 2026, revenue increased by 25.92% YoY to $31,109,000. However, net income dropped to -$10,913,000 (-32.76% YoY), and EPS fell to -0.29 (-45.28% YoY). Gross margin improved to 25.04%, up 14.81% YoY.
No data on analyst ratings or price target changes available.
